Skip to content

The effect of target oriented hemodynamic therapy on delayed early postoperative neurocognitive recovery and important organ function in high-risk patients undergoing personalized beach chair surgery

The effect of target oriented hemodynamic therapy on delayed early postoperative neurocognitive recovery and important organ function in high-risk patients undergoing personalized beach chair surgery

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087480
Enrollment
Unknown
Registered
2024-07-29
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early postoperative cognitive dysfunction

Interventions

Group A: individualized beach posture routine rehydration group:Individualized beach posture and routine rehydration
Group B: individualized beach posture goal-directed hemodynamic therapy group:Individualized beach posture and goal-directed hemodynamic therapy
Group C: traditional beach posture routine rehydration group:Traditional beach posture and routine rehydration
Group D: target directed hemodynamic therapy group in traditional beach posture:Traditional beach posture and goal-directed hemodynamic therapy

Sponsors

Xi’an Honghui Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Patients who were treated in our hospital for the first time under general anesthesia combined with brachial plexus block for unilateral proximal humerus fracture surgery; 2) ASA class I-III; 3) Age = 65 years; 4) BMI index 18-30kg/m2; 5) The patient graduated from primary school or above, and could sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) The patient refused to participate in this study; 2) Contraindications of brachial plexus block anesthesia; 3) Arrhythmia, congestive heart failure, severe heart valve disease; 4) Preoperative neurocognitive impairment, cerebrovascular events, and history of mental disorders; 5) Chronic obstructive pulmonary disease, chronic kidney disease; 6) Persistent infectious disease; 7) Pregnant patients and lactating women; 8) Patients with known allergy to any colloid; 9) Patients with severe vascular stenosis detected by transcranial Doppler ultrasound and carotid ultrasound.

Design outcomes

Primary

MeasureTime frame
Mini-mental State Examination (MMSE) 1 day before operation;Mini-mental State Examination (MMSE) 1 day after operation;Verbal fluency test (VFT) 1 day before operation;Verbal fluency test (VFT) 1 day after operation;Clock drawing test (CDT) 1 day before operation: 4 points;Clock drawing test (CDT) 1 day after operation: 4 points;Symbol Digit Modalities Test (SDMT) 1 day before operation;Symbol Digit Modalities Test (SDMT) 1 day after operation;Auditory verbal learning test (avlt) 1 day before operation;Auditory verbal learning test (avlt) 1 day after operation;Trial making test (TMT) 1 day before operation;Trial making test (TMT) 1 day after operation;Boston Naming Test (BNT) score 1 day before operation;Boston Naming Test (BNT) score 1 day after operation;

Secondary

MeasureTime frame
Intraoperative urapidil dose;Duration of low cerebral oxygen saturation;Blood biochemical values 1 day before and 1 day after operation;hemodynamic parameter;rSO 2 level;Height difference between blood pressure zero and external auditory canal;

Countries

China

Contacts

Public ContactWang Fang

Xi’an Honghui Hospital

2477557343@qq.com+86 139 9123 7605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026